Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers.
Li GS, Chen G, Liu J, Tang D, Zheng JH, Luo J, Jin MH, Lu HS, Bao CX, Tian J, Deng WS, Fu JW, Feng Y, Zeng NY, Zhou HF, Kong JL.
Li GS, et al. Among authors: liu j.
BMC Pulm Med. 2022 Jun 24;22(1):246. doi: 10.1186/s12890-022-02036-5.
BMC Pulm Med. 2022.
PMID: 35751045
Free PMC article.